Skip to content

The effect of training with an exoskeleton in people with frailty - a pilot study

The effect of training with an exoskeleton in people with frailty - a pilot study - Exo_Frail_Pilot

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00036342
Enrollment
10
Registered
2025-03-13
Start date
2025-02-10
Completion date
Unknown
Last updated
2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mobility in people with frailty

Interventions

Group 1: Intervention with exoskeleton: Inpatient geriatric complex program, according to the standard of the Clinic for Geriatric Medicine: 14-21 days of therapy. Regular therapies as in control arm
instead of regular physiotherapy: 5x/week 20-40 min adapted training with the Hal lumbar type exoskeleton. Visit 1 (baseline): regular geriatric and physiotherapeutic assessment including outcome pa
5x/week 20-40 min individual physiotherapy. Also group activities (relaxation training, board games). Visit 1 (baseline): regular geriatric and physiotherapeutic assessment including outcome paramete

Sponsors

Klinik für Altersmedizin
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to No maximum

Inclusion criteria

Inclusion criteria: - Patients with frailty according to Clinical Frailty Scale (CFS) 4, 5 or 6. - Indication for a 'Geriatric Complex Programme' (GCP) is given

Exclusion criteria

Exclusion criteria: - Patients included in the GCP without clinically relevant frailty (CFS 6) - Patient not able to give consent - Relevant pre-existing conditions that a) are a medical contraindication for training (unstable angina pectoris, decompensated heart failure, symptomatic aortic valve stenosis, acute myocarditis, symptomatic hypertrophic obstructive cardiomyopathy, systemic inflammatory disease) b) Prevent performance of the ‘timed up and go’ test (severe rheumatic diseases, recent fractures, hip or knee joint surgery, severe polyneuropathy) c) as skin diseases prevent the application of electrodes - General reasons that speak against conducting an inpatient GCP - Pre-existing, severe cognitive impairment, e.g. in the context of dementia

Design outcomes

Primary

MeasureTime frame
Function of the exercised muscle groups: assessed in V1 and V2 using the Tinetti test.

Secondary

MeasureTime frame
Muscle function: measured at V1 and V2 using timed “up and go” test and 30 m walk test. Quality of life: measured at V1 and V3 using the SF-36 = Short Form-36 Health Survey questionnaire. Functionality and independence: measured at V1 and V3 using the FIM-Score = Functional Independence Measure Score questionnaire. Fear of falling: measured at V1, V2 and V3 using the FES-I = Falls Efficacy Scale - International Version questionnaire.

Countries

Germany

Contacts

Public ContactHannah Mühlhammer

Klinik für Altersmedizin

hannah.muehlhammer@uk-halle.de+49 345 557 7137

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026